These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 24260330)
21. Association of p53 Arg72Pro polymorphism with esophageal cancer: a meta-analysis based on 14 case-control studies. Zhao L; Zhao X; Wu X; Tang W Genet Test Mol Biomarkers; 2013 Oct; 17(10):721-6. PubMed ID: 23844939 [TBL] [Abstract][Full Text] [Related]
22. No association between Zhang A; Shi TY; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Hu Y; Wang D; He J; Duan P Oncotarget; 2017 Dec; 8(68):112761-112769. PubMed ID: 29348863 [TBL] [Abstract][Full Text] [Related]
23. The Role of TP53 Gene Codon 72 Polymorphism in Leukemia: A PRISMA-Compliant Systematic Review and Meta-Analysis. Ruan XL; Li S; Meng XY; Geng P; Gao QP; Ao XB Medicine (Baltimore); 2015 Sep; 94(38):e1588. PubMed ID: 26402821 [TBL] [Abstract][Full Text] [Related]
24. Association between p53 Arg72Pro polymorphism and thyroid cancer risk: a meta-analysis. Wu B; Guo D; Guo Y Tumour Biol; 2014 Jan; 35(1):561-5. PubMed ID: 24037912 [TBL] [Abstract][Full Text] [Related]
25. p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis. Weng Y; Lu L; Yuan G; Guo J; Zhang Z; Xie X; Chen G; Zhang J PLoS One; 2012; 7(9):e45820. PubMed ID: 23029260 [TBL] [Abstract][Full Text] [Related]
26. P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians. Xu T; Xu ZC; Zou Q; Yu B; Huang XE Asian Pac J Cancer Prev; 2012; 13(5):2349-54. PubMed ID: 22901221 [TBL] [Abstract][Full Text] [Related]
27. p53 codon 72 polymorphism and endometriosis: a meta-analysis. Jia S; Xu L; Chan Y; Wu X; Yang S; Yu H; Yang H; Luo Y; Tang W Arch Gynecol Obstet; 2012 Jun; 285(6):1657-61. PubMed ID: 22258307 [TBL] [Abstract][Full Text] [Related]
28. The Pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer risk. Proestling K; Hebar A; Pruckner N; Marton E; Vinatzer U; Schreiber M PLoS One; 2012; 7(10):e47325. PubMed ID: 23071787 [TBL] [Abstract][Full Text] [Related]
29. Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis. Zhou X; Gu Y; Zhang SL Asian Pac J Cancer Prev; 2012; 13(10):4909-14. PubMed ID: 23244080 [TBL] [Abstract][Full Text] [Related]
30. Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk. Nan H; Qureshi AA; Hunter DJ; Han J Br J Dermatol; 2008 Aug; 159(2):314-21. PubMed ID: 18510673 [TBL] [Abstract][Full Text] [Related]
31. Contribution of polymorphism in codon 72 of TP53 gene to laryngeal cancer in Polish patients. Zemleduch T; Lianeri M; Rydzanicz M; Gajecka M; Szyfter K; Jagodziński PP Oral Oncol; 2009 Aug; 45(8):683-6. PubMed ID: 19091625 [TBL] [Abstract][Full Text] [Related]
32. Meta-analysis of association between the TP53 Arg72Pro polymorphism and risk of endometriosis based on case-control studies. Yan Y; Wu R; Li S; He J Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():1-7. PubMed ID: 25819169 [TBL] [Abstract][Full Text] [Related]
33. Increased risk of cutaneous melanoma associated with p53 Arg72Pro polymorphism. Geng P; Liao Y; Ruan Z; Liang H PLoS One; 2015; 10(3):e0118112. PubMed ID: 25774791 [TBL] [Abstract][Full Text] [Related]
34. Evaluating the association between p53 codon 72 Arg>pro polymorphism and risk of ovary cancer: a meta-analysis. Alqumber MA; Akhter N; Haque S; Panda AK; Mandal RK PLoS One; 2014; 9(4):e94874. PubMed ID: 24747975 [TBL] [Abstract][Full Text] [Related]
35. TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis. Peng Q; Lao X; Chen Z; Lai H; Deng Y; Wang J; Mo C; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S PLoS One; 2013; 8(12):e82773. PubMed ID: 24376578 [TBL] [Abstract][Full Text] [Related]
36. Association between p53 Arg72Pro polymorphism and the risk of human papillomavirus-related head and neck squamous cell carcinoma: a meta-analysis. Xia LY; Zeng XT; Li C; Leng WD; Fan MW Asian Pac J Cancer Prev; 2013; 14(10):6127-30. PubMed ID: 24289637 [TBL] [Abstract][Full Text] [Related]
37. Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis. Ruan XL; Li S; Geng P; Zeng XT; Yu GZ; Meng XY; Gao QP; Ao XB Med Sci Monit; 2015 Oct; 21():3048-53. PubMed ID: 26451982 [TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of associations between ATM Asp1853Asn and TP53 Arg72Pro polymorphisms and adverse effects of cancer radiotherapy. Su M; Yin ZH; Wu W; Li XL; Zhou BS Asian Pac J Cancer Prev; 2014; 15(24):10675-81. PubMed ID: 25605158 [TBL] [Abstract][Full Text] [Related]
39. [p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population]. Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):76-9. PubMed ID: 15774209 [TBL] [Abstract][Full Text] [Related]
40. P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility. Hou J; Gu Y; Hou W; Wu S; Lou Y; Yang W; Zhu L; Hu Y; Sun M; Xue H BMC Genet; 2015 Jun; 16():72. PubMed ID: 26123760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]